Your account is not claimed yet. You can sign up with ORCID to claim your account.

Peixun Zhou

Years Active: 2020-2021
Publications (10 Years): 3

Teesside University

University of Glasgow (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Teesside University Nov 1o 2019

United Kingdom

Research Associate :: National Horizons Centre

Education History

University of Glasgow Oct 1o 2007

United Kingdom

PHD :: Paul O'Gorman Leukaemia Research Centre

Publications

Carmela Ciardullo, Katarzyna Szoltysek, Peixun Zhou, Monika Pietrowska, Lukasz Marczak, Elaine Willmore, Amir Enshaei, Anna Walaszczyk, Jia Yee Ho, Vikki Rand, Scott Marshall, Andrew G Hall, Christine J Harrison, Meera Soundararajan, Jeyanthy Eswaran
Low BACH2 Expression Predicts Adverse Outcome in Chronic Lymphocytic Leukaemia. Cancers 14 (1) (2021)
Peixun Zhou, Alex E Blain, Alexander M Newman, Masood Zaka, George Chagaluka, Filbert R Adlar, Ugonna T Offor, Casey Broadbent, Lewis Chaytor, Amber Whitehead, Amy Hall, Hettie O'Connor, Susan Van Noorden, Irvin Lampert, Simon Bailey, Elizabeth M Molyneux, Chris M Bacon, Simon Bomken, Vikki Rand
Sporadic and endemic Burkitt lymphoma have frequent FOXO1 mutations but distinct hotspots in the AKT recognition motif. Blood advances 3 (14) (2020)
Katarzyna Szoltysek, Carmela Ciardullo, Peixun Zhou, Anna Walaszczyk, Elaine Willmore, Vikki Rand, Scott Marshall, Andy Hall, Christine J Harrison, Jeyanthy Eswaran, Meera Soundararajan
DAP Kinase-Related Apoptosis-Inducing Protein Kinase 2 (DRAK2) Is a Key Regulator and Molecular Marker in Chronic Lymphocytic Leukemia. International journal of molecular sciences 21 (20) (2020)

Peixun Zhou.css-eqlu8i{font-size:small;padding-left:4px;}